Novartis

Company Snapshot
Lichtstrasse 35
Basel, 4056
Switzerland
Sector: Healthcare
Industry: Drug Manufacturers - General
Full Time Employees: 118,393
http://www.novartis.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
$34,777,000,000
$37,010,000,000
$36,342,000,000
Operating Income
$10,152,000,000
$11,689,000,000
$9,197,000,000
Net Income
$8,072,000,000
$24,021,000,000
$6,955,000,000
2020
Gross Profit
$34,777,000,000
Operating Income
$10,152,000,000
Net Income
$8,072,000,000
2021
Gross Profit
$37,010,000,000
Operating Income
$11,689,000,000
Net Income
$24,021,000,000
2022
Gross Profit
$36,342,000,000
Operating Income
$9,197,000,000
Net Income
$6,955,000,000
The above data on Novartis came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Vasant Narasimhan
Chief Executive Officer
$3,128,625
$7,158,082
$673,933
$10,960,640
Vasant Narasimhan
$10,960,640
Chief Executive Officer
Harry Kirsch
Chief Financial Officer
$1,738,070
$3,474,322
$213,982
$5,426,374
Harry Kirsch
$5,426,374
Chief Financial Officer
Aharon Gal
Chief Strategy and Growth Officer
$513,441
$150,043
$4,654,802
$5,318,286
Aharon Gal
$5,318,286
Chief Strategy and Growth Officer
Marie-France Tschudin
President, Innovative Medicines International and Chief Commercial Officer
$1,478,459
$2,747,296
$173,284
$4,399,039
Marie-France Tschudin
$4,399,039
President, Innovative Medicines International and Chief Commercial Officer
Fiona Marshall
President, Novartis Institutes for BioMedical Research
$287,239
$101,163
$3,977,286
$4,365,688
Fiona Marshall
$4,365,688
President, Novartis Institutes for BioMedical Research
Novartis listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us